Tech Company M&A Transactions
Selah Genomics Acquisition
Operating out of Greenville, Selah Genomics was purchased by EKF Diagnostics. EKF Diagnostics said the transaction price was $75 million.
Transaction Overview
Company Name
Acquired By
Announced On
4/18/2014
Transaction Type
M&A
Amount
$75,000,000
M&A Terms
The deal involves an upfront payment of $40 million in stock, the statement said, with an additional $35 million in stock on offer on the completion of certain milestones.
Company Information
Company Status
Acquired or Merged
Industry
Nanotechnology
Mailing Address
411 University Ridge A
Greenville, SC 29601
USA
Greenville, SC 29601
USA
Phone
Website
Email Address
Overview
Selah Genomics is a clinical diagnostic specialist supporting healthcare providers and the pharmaceutical industry with advanced molecular and genomic diagnostic services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Bolick
Chief Scientific Officer
Jeremy Stuart
VP - Operations
Melissa Rayner
VP - Sales
Jennifer Lawrence
Browse more venture capital transactions:
Prev: 4/17/2014: EPIRUS Biopharmaceuticals venture capital transaction
Next: 4/18/2014: Profectus BioSciences venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs